Tower Research Capital LLC (Trc) Care Dx, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Care Dx, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 600 shares of CDNA stock, worth $13,446. This represents 0.0% of its overall portfolio holdings.
Number of Shares
600
Previous 7,451
91.95%
Holding current value
$13,446
Previous $115,000
84.35%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding CDNA
# of Institutions
222Shares Held
50.7MCall Options Held
97.3KPut Options Held
43.3K-
Black Rock Inc. New York, NY5.29MShares$118 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$102 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.15MShares$70.5 Million1.65% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.41MShares$54 Million0.45% of portfolio
-
State Street Corp Boston, MA2.04MShares$45.6 Million0.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.2B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...